TL;DR
Cleveland anchors a distinctive medical device cluster centered on Cleveland Clinic spinouts (orthopedic, cardiovascular, surgical robotics), STERIS' sterilization and surgical products footprint, and a deep bench of mid-market device manufacturers. The cluster's insurance signature is Class II and III implantable products liability with surgical and cardiovascular focus, plus the GPO supplier insurance compliance characteristic of hospital-supplier device manufacturers.
Cleveland medical device
Cleveland medical device insurance - Cleveland Clinic spinouts, STERIS, cardiovascular device cluster.
Cleveland has built one of the densest US medical device clusters around the Cleveland Clinic ecosystem. Spinouts from the Cleveland Clinic Innovations program produce a steady flow of orthopedic, cardiovascular, and surgical robotics operators. STERIS anchors the sterilization and surgical products segment. A deep bench of mid-market device manufacturers serves both Cleveland Clinic and the broader Midwest hospital network.
Cluster characteristics
Implantable cardiovascular and orthopedic dominate.
Cleveland Clinic spinouts typically launch with Cleveland Clinic Innovations licensing terms. Insurance programs need to satisfy those terms (indemnity wording, additional insured for Cleveland Clinic, specific claim notification protocols) while remaining economically viable at clinical-stage revenue.
STERIS (Mentor) operates across surgical sterilization, infection prevention, and surgical instrumentation. Insurance programs for STERIS-tier suppliers face hospital purchase contract demands typical of Class II device manufacturers.
Mid-market cardiovascular and orthopedic device manufacturers in the cluster need $25M plus products liability towers with occurrence-form preferred due to long implantable claim tails, MDR liability extensions, and GPO supplier insurance for hospital purchase contracts.
Ohio regulatory overlay
ODH device facility oversight, ODI cyber, moderate securities posture.
The Ohio Department of Health (ODH) maintains medical device facility registration and inspection programs that interact with FDA QSR/QMSR oversight. Operators should expect parallel state and federal inspection scrutiny on quality management systems.
Ohio has not enacted a comprehensive state privacy law as of 2026, so cyber liability programs focus on HIPAA and any applicable downstream-state regulations rather than Ohio-specific overlays.
Securities-class-action posture in Northern District of Ohio is moderate for post-IPO operators. D&O architecture for Cleveland-headquartered public device manufacturers should anticipate standard products liability disclosure exposure on Class III implantable adverse event reporting.
Premium levels for Cleveland device operators track at parity with comparable Texas operators on standard lines, with implantable products liability priced individually based on product class and claim tail.
Cleveland device coverage review